Eighteen months or so after losing a piece of the Viagra business to R/GA, Digitas has realigned with Pfizer as sources familiar with the matter confirm that the latter agency has been handed AOR duties for the Chantix (aka Varenicline) business. The account for the smoking cessation drug had previously been handled by McGarryBowen, which took over for McCann in early 2009 (as we know, it wouldn’t be the last time we’d see this happen in ’09). Pfizer hasn’t responded as of yet to our request for comment.
Update: We’ve been told by tipsters that Chantix is now being handled by Digitas HEALTH, which has already been working on the digital part of the account.
Advertisement